MetLife Inc 4.75% Series F Preferred Stock
MET.PRF
3 hedge funds and large institutions have $305K invested in MetLife Inc 4.75% Series F Preferred Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
639% more capital inflows, than outflows
Capital inflows: $289K | Capital outflows: $39.1K
0.03% more ownership
Funds ownership: 0.01% → 0.04% (+0.03%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ethos Financial Group
King Of Prussia,
Pennsylvania
|
+$271K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
3Chopt Investment Partners
Richmond,
Virginia
|
-$39.1K |
MET.PRF Hedge Fund Activity: Q1 2023 in Review
3 of the 6,289 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 4.75% Series F Preferred Stock (MET.PRF) for Q1 2023, worth a combined $305K — up 479% from $52.6K a quarter earlier.
Fund positioning in MET.PRF was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Ethos Financial Group, opening a new position worth an estimated $271K. The largest seller was 3Chopt Investment Partners, exiting entirely with an estimated $39.1K sold.
- 3 institutional investors held MetLife Inc 4.75% Series F Preferred Stock (MET.PRF) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $305K of MetLife Inc 4.75% Series F Preferred Stock stock for Q1 2023, up 479% quarter-over-quarter.
- 1 fund opened new MetLife Inc 4.75% Series F Preferred Stock positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest MetLife Inc 4.75% Series F Preferred Stock buyer in Q1 2023 was Ethos Financial Group, an estimated $271K added.
- The largest MetLife Inc 4.75% Series F Preferred Stock seller in Q1 2023 was 3Chopt Investment Partners, an estimated $39.1K sold.
Based on aggregated 13F filings for Q1 2023.